Elise Reuter

Ben Newton, GE HealthCare’s global head of oncology, said the partnership will shift radiation therapy from a “one-size-fits-all” approach to a personalized method.

An FDA warning letter about the wearable company’s blood pressure feature raises questions about the blurring lines between medtech and wellness.

Stiles has worked at Stryker for 27 years, most recently leading the company’s orthopedics business.

The partnership is the first time Medtronic has integrated its insulin pumps with a sensor developed outside of the company.

Denny leads the unit after Medtronic combined its patient monitoring and respiratory businesses last year.

AdvaMed supported changes made from a draft version but still has concerns about the impact on patient access.

The CMS could use its competitive bidding program to address price concerns, after payments for the devices swelled over five years, the government watchdog said.

Peichel, who has worked at Medtronic for more than 25 years, succeeds Ken Washington, who retired earlier this month.

The problem applies to Abbott’s Libre 3 and Libre 3 Plus sensors. The company said it has received reports of 736 severe adverse events and seven deaths.

The medtech firm plans to launch its next flagship patch-pump in 2027, and its first fully closed loop system for Type 2 diabetes in 2028.

The proposed deal, the biggest under CEO Robert Ford’s tenure, would allow Abbott to enter a large, new market for cancer testing. 

The purchase would give Abbott access to cancer screening tests including Cologuard and blood tests for multi-cancer early detection.

The incoming AdvaMed chair talked about updates to Resmed’s products and how the company is handling competitive dynamics and tariffs.

The collaboration will pair biometric data from the Oura ring with information from glucose sensors and insulin pumps.

CEO Ivan Tornos said multiple factors emerged late in the quarter that caused the shortfall. Zimmer’s shares plunged more than 15%.

In a letter to CMS Administrator Mehmet Oz, diabetes caucus leaders raised concerns that the agency’s proposals will reduce access to glucose monitors and insulin pumps.

A software defect could cause the app to terminate, resulting in missed alerts or alarms. Dexcom required users to download an update.

After dealing with a deployment issue with glucose monitors earlier this year, interim CEO Jake Leach said improving customer service has also been a focus for the company.

The notice follows inspections of three Philips facilities that found failures to meet standards for reporting complaints and corrective actions.

The purchase is expected to complement Thermo’s clinical research services, as companies are conducting more trials.